{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:41:44Z","timestamp":1795113704629,"version":"4.10.3"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.atherosclerosis.2025.119214","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T06:06:11Z","timestamp":1746165971000},"page":"119214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Homozygous familial hypercholesterolemia evaluation and survival single center study in Saudi Arabia: The HESSA registry"],"prefix":"10.1016","volume":"405","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6914-0730","authenticated-orcid":false,"given":"Naji","family":"Kholaif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Batha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumayah","family":"Aljenedil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhier Ahmed","family":"Awan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadiah","family":"AlRuwaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman Khalid","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Awni","family":"Jouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Savo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadl Elmula M.","family":"Fadl Elmula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir I.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Al-Ashwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Pergola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser","family":"Elkum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Galzerano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.119214_bib1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9343(75)90563-X","article-title":"Familial hypercholesterolemia. A genetic regulatory defect in cholesterol metabolism","volume":"58","author":"Goldstein","year":"1975","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.119214_bib2","article-title":"Management and clinical outcomes of patients with homozygous familial hypercholesteremia in Saudi Arabia","volume":"93","author":"Kholaif","year":"2023","journal-title":"Monaldi Arch Chest Dis"},{"issue":"10326","key":"10.1016\/j.atherosclerosis.2025.119214_bib3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(21)02001-8","article-title":"Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study","volume":"399","author":"Tromp","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2025.119214_bib4","first-page":"45","article-title":"Fatal myocardial infarction at 4.5 years in a case of homozygous familial hypercholesterolaemia","volume":"2","author":"Gautschi","year":"2012","journal-title":"JIMD Rep"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.119214_bib5","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.amjcard.2008.07.035","article-title":"Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia","volume":"102","author":"Kolansky","year":"2008","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2025.119214_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.cjca.2019.06.009","article-title":"The lifelong burden of homozygous familial hypercholesterolemia","volume":"35","author":"Banerjee","year":"2019","journal-title":"Can J Cardiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.119214_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100309","article-title":"Homozygous familial hypercholesterolemia in Canada: an observational study","volume":"2","author":"Brown","year":"2023","journal-title":"JACC Adv"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2025.119214_bib8","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/eurheartj\/ehad197","article-title":"2023 update on european atherosclerosis society consensus statement on homozygous familial hypercholesterolaemia: new treatments and clinical guidance","volume":"44","author":"Cuchel","year":"2023","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.119214_bib9","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurjpc\/zwae036","article-title":"Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN registry","volume":"31","author":"D'Erasmo","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.119214_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.atherosclerosis.2018.06.878","article-title":"Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia","volume":"277","author":"Alnouri","year":"2018","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.119214_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251560","article-title":"Familial hypercholesterolemia in the arabian gulf region: clinical results of the gulf FH registry","volume":"16","author":"Alhabib","year":"2021","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.119214_bib12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/jmg.32.8.623","article-title":"Consanguinity among the Saudi Arabian population","volume":"32","author":"el-Hazmi","year":"1995","journal-title":"J Med Genet"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.119214_bib13","first-page":"1881","article-title":"Regional variations in the prevalence of consanguinity in Saudi Arabia","volume":"28","author":"El-Mouzan","year":"2007","journal-title":"Saudi Med J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119214_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ygeno.2015.12.001","article-title":"Identification of a recurrent frameshift mutation at the LDLR exon 14 (c.2027delG, p.(G676Afs\u221733)) causing familial hypercholesterolemia in saudi Arab homozygous children","volume":"107","author":"Al-Allaf","year":"2016","journal-title":"Genomics"},{"key":"10.1016\/j.atherosclerosis.2025.119214_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/hgv.2014.21","article-title":"Identification of a novel nonsense variant c.1332dup, p.(D445\u2217) in the LDLR gene that causes familial hypercholesterolemia","volume":"1","author":"Al-Allaf","year":"2014","journal-title":"Hum Genome Var"},{"key":"10.1016\/j.atherosclerosis.2025.119214_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1454638","article-title":"The effectiveness of liver transplantation in reducing lipid levels in Saudi children with homozygous familial hypercholesterolemia","volume":"11","author":"Al-Ashwal","year":"2024","journal-title":"Front Cardiovasc Med"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2025.119214_bib17","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"issue":"34","key":"10.1016\/j.atherosclerosis.2025.119214_bib18","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1021\/acs.jpcb.2c04346","article-title":"AlphaFold, artificial intelligence (AI), and allostery","volume":"126","author":"Nussinov","year":"2022","journal-title":"J Phys Chem B"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.119214_bib19","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S2213-8587(24)00233-X","article-title":"Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study","volume":"12","author":"Masana","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2025.119214_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2016.10.028","article-title":"Spectrum of mutations in homozygous familial hypercholesterolemia in India, with four novel mutations","volume":"255","author":"Setia","year":"2016","journal-title":"Atherosclerosis"},{"issue":"6218","key":"10.1016\/j.atherosclerosis.2025.119214_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/science.1254806","article-title":"RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease","volume":"347","author":"Xiong","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119214_bib22","first-page":"75","article-title":"Compound heterozygous LDLR variant in severely affected familial hypercholesterolemia patient","volume":"64","author":"Al-Allaf","year":"2017","journal-title":"Acta Biochim Pol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119214_bib23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/sj.ki.5002273","article-title":"Chronic kidney disease management in the United Kingdom: NEOERICA project results","volume":"72","author":"Stevens","year":"2007","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2025.119214_bib24","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jama.2015.1206","article-title":"Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus","volume":"313","author":"Besseling","year":"2015","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.119214_bib25","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/ATVBAHA.123.320268","article-title":"Evolocumab treatment in pediatric patients with homozygous familial hypercholesterolemia: pooled data from three open-label studies","volume":"44","author":"Raal","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.119214_bib26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s12325-023-02764-y","article-title":"The effect of PCSK9 inhibitors on LDL-C target achievement in patients with homozygous familial hypercholesterolemia: a retrospective cohort analysis","volume":"41","author":"Alshahrani","year":"2024","journal-title":"Adv Ther"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.119214_bib27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S2352-4642(24)00073-7","article-title":"Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries","volume":"8","author":"Reijman","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"issue":"9860","key":"10.1016\/j.atherosclerosis.2025.119214_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(12)61731-0","article-title":"Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study","volume":"381","author":"Cuchel","year":"2013","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.119214_bib29","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa2004215","article-title":"Evinacumab for homozygous familial hypercholesterolemia","volume":"383","author":"Raal","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.119214_bib30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/CIRCULATIONAHA.123.065529","article-title":"Evinacumab for pediatric patients with homozygous familial hypercholesterolemia","volume":"149","author":"Wiegman","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.119214_bib31","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1016\/j.jacl.2023.12.003","article-title":"Modern approaches to the management of homozygous familial hypercholesterolemia in the Middle East and North Africa","volume":"18","author":"Al-Ashwal","year":"2024","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2025.119214_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0002-9343(64)90196-2","article-title":"The inheritance of essential familial hypercholesterolemia","volume":"37","author":"Khachadurian","year":"1964","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.119214_bib33","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/BF00420940","article-title":"South African founder mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia in the Dutch population","volume":"92","author":"Defesche","year":"1993","journal-title":"Hum Genet"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.119214_bib34","first-page":"443","article-title":"A common Lithuanian mutation causing familial hypercholesterolemia in Ashkenazi jews","volume":"49","author":"Meiner","year":"1991","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.119214_bib35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/01.ATV.9.2.211","article-title":"Homozygous familial hypercholesterolemia among french Canadians in Quebec province","volume":"9","author":"Moorjani","year":"1989","journal-title":"Arteriosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.119214_bib36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ymgme.2010.11.006","article-title":"Homozygous familial hypercholesterolemia in Lebanon: a genotype\/phenotype correlation","volume":"102","author":"Fahed","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.atherosclerosis.2025.119214_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.694668","article-title":"Saudi familial hypercholesterolemia patients with rare LDLR stop gain variant showed variable clinical phenotype and resistance to multiple drug regimen","volume":"8","author":"Awan","year":"2021","journal-title":"Front Med"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.119214_bib38","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/nar\/gkw010","article-title":"Mechanism and regulation of the nonsense-mediated decay pathway","volume":"44","author":"Hug","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119214_bib39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/ATVBAHA.112.301131","article-title":"The critical role of mRNA destabilizing protein heterogeneous nuclear ribonucleoprotein d in 3' untranslated region-mediated decay of low-density lipoprotein receptor mRNA in liver tissue","volume":"34","author":"Singh","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4701","key":"10.1016\/j.atherosclerosis.2025.119214_bib40","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1126\/science.2988123","article-title":"The LDL receptor gene: a mosaic of exons shared with different proteins","volume":"228","author":"Sudhof","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2025.119214_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2024.103463","article-title":"Generation of two familial hypercholesterolemia patient-specific induced pluripotent stem cell lines harboring heterozygous mutations in the LDLR gene","volume":"78","author":"Gao","year":"2024","journal-title":"Stem Cell Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119214_bib42","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1038\/s41598-019-41056-w","article-title":"Function and immunogenicity of gene-corrected iPSC-derived hepatocyte-like cells in restoring low density lipoprotein uptake in homozygous familial hypercholesterolemia","volume":"9","author":"Okada","year":"2019","journal-title":"Sci Rep"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025001121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025001121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T03:51:19Z","timestamp":1747972279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025001121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":42,"alternative-id":["S0021915025001121"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119214","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homozygous familial hypercholesterolemia evaluation and survival single center study in Saudi Arabia: The HESSA registry","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119214"}}